The effects of Valeriana officinalis L. hydro-alcoholic extract on depression like behavior in ovalbumin sensitized rats - PubMed
The effects of Valeriana officinalis L. hydro-alcoholic extract on depression like behavior in ovalbumin sensitized rats
Ali Neamati et al. J Pharm Bioallied Sci. 2014 Apr.
Abstract
Background: Neuroimmune factors have been considered as contributors to the pathogenesis of depression. Beside other therapeutic effects, Valeriana officinalis L., have been suggested to have anti-inflammatory effects. In the present study, the effects of V. officinalis L. hydro alcoholic extract was investigated on depression like behavior in ovalbumin sensitized rats.
Materials and methods: A total of 50 Wistar rats were divided into five groups: Group 1 (control group) received saline instead of Valeriana officinalis L. extract. The animals in group 2 (sensitized) were treated by saline instead of the extract and were sensitized using the ovalbumin. Groups 3-5 (Sent - Ext 50), (Sent - Ext 100) and (Sent - Ext 200) were treated by 50, 100 and 200 mg/kg of V. officinalis L. hydro-alcoholic extract respectively, during the sensitization protocol. Forced swimming test was performed for all groups and immobility time was recorded. Finally, the animals were placed in the open-field apparatus and the crossing number on peripheral and central areas was observed.
Results: The immobility time in the sensitized group was higher than that in the control group (P < 0.01). The animals in Sent-Ext 100 and Sent-Ext 200 groups had lower immobility times in comparison with sensitized group (P < 0.05 and P < 0.01). In the open field test, the crossed number in peripheral by the sensitized group was higher than that of the control one (P < 0.01) while, the animals of Sent-Ext 50, Sent-Ext 100 and Sent-Ext 200 groups had lower crossing number in peripheral compared with the sensitized group (P < 0.05 and P < 0.01 respectively). Furthermore, in the sensitized group, the central crossing number was lower than that of the control group (P < 0.001). In the animals treated by 200 mg/kg of the extract, the central crossing number was higher than that of the sensitized group (P < 0. 05).
Conclusions: The results of the present study showed that the hydro-alcoholic extract of V. officinalis prevents depression like behavior in ovalbumin sensitized rats. These results support the traditional belief on the about beneficial effects of V. officinalis in the nervous system. Moreover, further investigations are required in order to better understand this protective effect.
Keywords: Depression; Valeriana officinalis; forced swimming test; open-field; ovalbumin; sensitized.
Conflict of interest statement
Conflict of Interest: None declared.
Figures

Comparison of immobility times in the forced swimming test between five groups. Data are expressed as mean ± standard error of the mean (n = 10 in each group). **P < 0.01 comparison of sensitized group with control group, +P < 0.05 and ++P < 0.01 comparison of sensitized animals treated by 100 and 200 mg/kg of the extract respectively groups with non treated sensitized group. The two ANOVA followed by Tukey post hoc test. The criterion for the statistical significance was P < 0.05

Comparison of the number of crossing in the peripheral zone in the open-field test. Data are expressed as mean ± standard error of the mean (n = 10 in each group). **P < 0.01 comparison of sensitized group with control group, +P < 0.05 and ++P < 0.01 comparison of sensitized animals treated by 50, 100 and 200 mg/kg of the extract respectively, with non-treated sensitized group. The two ANOVA followed by Tukey post hoc test. The criterion for the statistical significance was P < 0.05

Comparison of the number of crossing in the central zone in the open-field test. Data are expressed as mean ± standard error of the mean (n = 10 in each group). ***P < 0.001 comparison of sensitized group with control group, +P < 0.05 comparison of sensitized animals treated by 200 mg/kg of the extract with non-treated sensitized group. The two ANOVA followed by Tukey post hoc test. The criterion for the statistical significance was P < 0.05

Comparison of the number of rearing in the open-field test. Data are expressed as mean ± standard error of the mean (n = 10 in each group). The two ANOVA followed by Tukey post hoc test. The criterion for the statistical significance was P < 0.05
Similar articles
-
Norouzi F, Abareshi A, Anaeigoudari A, Shafei MN, Gholamnezhad Z, Saeedjalali M, Mohebbati R, Hosseini M. Norouzi F, et al. Avicenna J Phytomed. 2016 Jan-Feb;6(1):104-16. Avicenna J Phytomed. 2016. PMID: 27247927 Free PMC article.
-
Hosseini M, Zakeri S, Khoshdast S, Yousefian FT, Rastegar M, Vafaee F, Kahdouee S, Ghorbani F, Rakhshandeh H, Kazemi SA. Hosseini M, et al. J Pharm Bioallied Sci. 2012 Jul;4(3):219-25. doi: 10.4103/0975-7406.99052. J Pharm Bioallied Sci. 2012. PMID: 22923964 Free PMC article.
-
Ghazizadeh J, Hamedeyazdan S, Torbati M, Farajdokht F, Fakhari A, Mahmoudi J, Araj-Khodaei M, Sadigh-Eteghad S. Ghazizadeh J, et al. Exp Physiol. 2020 Apr;105(4):707-720. doi: 10.1113/EP088254. Epub 2020 Feb 21. Exp Physiol. 2020. PMID: 32003913
-
Homayoun M, Seghatoleslam M, Pourzaki M, Shafieian R, Hosseini M, Ebrahimzadeh Bideskan A. Homayoun M, et al. Avicenna J Phytomed. 2015 May-Jun;5(3):260-70. Avicenna J Phytomed. 2015. PMID: 26101759 Free PMC article.
-
Rahmati B, Kiasalari Z, Roghani M, Khalili M, Ansari F. Rahmati B, et al. Pharm Biol. 2017 Dec;55(1):958-965. doi: 10.1080/13880209.2017.1285320. Pharm Biol. 2017. PMID: 28166686 Free PMC article.
Cited by
-
Kumari B, Kumari U, Singh DK, Husain GM, Patel DK, Shakya A, Singh RB, Modi GP, Singh GK. Kumari B, et al. Endocr Metab Immune Disord Drug Targets. 2024;24(13):1506-1517. doi: 10.2174/0118715303262653231120043819. Endocr Metab Immune Disord Drug Targets. 2024. PMID: 38375842 Review.
-
The effects of captopril on lipopolysaccharide-induced sickness behaviors in rats.
Abareshi A, Anaeigoudari A, Norouzi F, Marefati N, Beheshti F, Saeedjalali M, Hosseini M. Abareshi A, et al. Vet Res Forum. 2019 Summer;10(3):199-205. doi: 10.30466/vrf.2018.90760.2198. Epub 2019 Sep 15. Vet Res Forum. 2019. PMID: 31737228 Free PMC article.
-
Jahani R, Khaledyan D, Jahani A, Jamshidi E, Kamalinejad M, Khoramjouy M, Faizi M. Jahani R, et al. Res Pharm Sci. 2019 Dec 11;14(6):544-553. doi: 10.4103/1735-5362.272563. eCollection 2019 Dec. Res Pharm Sci. 2019. PMID: 32038734 Free PMC article.
-
Norouzi F, Abareshi A, Anaeigoudari A, Shafei MN, Gholamnezhad Z, Saeedjalali M, Mohebbati R, Hosseini M. Norouzi F, et al. Avicenna J Phytomed. 2016 Jan-Feb;6(1):104-16. Avicenna J Phytomed. 2016. PMID: 27247927 Free PMC article.
-
Awareness and current knowledge of epilepsy.
Khan AU, Akram M, Daniyal M, Akhter N, Riaz M, Akhtar N, Shariati MA, Anjum F, Khan SG, Parveen A, Ahmad S. Khan AU, et al. Metab Brain Dis. 2020 Jan;35(1):45-63. doi: 10.1007/s11011-019-00494-1. Epub 2019 Oct 11. Metab Brain Dis. 2020. PMID: 31605258 Review.
References
-
- Sharp LK, Lipsky MS. Screening for depression across the lifespan: A review of measures for use in primary care settings. Am Fam Physician. 2002;66:1001–8. - PubMed
-
- Spitzer RL, Kroenke K, Linzer M, Hahn SR, Williams JB, deGruy FV, 3rd, et al. Health-related quality of life in primary care patients with mental disorders. Results from the PRIME-MD 1000 Study. JAMA. 1995;274:1511–7. - PubMed
-
- Coulehan JL, Schulberg HC, Block MR, Madonia MJ, Rodriguez E. Treating depressed primary care patients improves their physical, mental, and social functioning. Arch Intern Med. 1997;157:1113–20. - PubMed
-
- Fava M, Davidson KG. Definition and epidemiology of treatment- resistant depression. Psychiatr Clin North Am. 1996;19:179–200. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources